Venus Remedies has already submitted dossiers to the Health Ministry of the Philippines for additional 45 marketing authorisations, and mos...

The development comes three months after the company received good manufacturing practices (GMP) certification from the Saudi Food and Drug...

Docetaxel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcin...

Shilpa Medicare has received USFDA final approval for its abbreviated new drug application.

The development follows a price revision as per annual Wholesale Price Index (WPI) at the rate of 3.44 percent increase, the National Pharm...

Health regulators raised a red flag over a defect in the sealing of Docetaxel injection vials- a drug used for treating breast cancer.

It affects the lowermost segment of the uterus and is the second most common cancer affecting women in the reproductive age-group of 15-44 ...

Docetaxel injection USP 20 mg/mL and 80 mg/4 mL are available as a single dose, one vial formulation that does not require a prior dilution.

Intas Pharmaceuticals Ltd has announced that Singapore investment company Temasek has acquired a 10.16% equity stake in the company.

Venus Remedies has received approval from Australian authorities for 4 of its facilities, thus enabling the company to export products from...

The company said on Thursday that its lung cancer drug Erlocip would cost Rs 9,900 for 30 tablets instead of Rs 27,000 and Rs 3,700 for 10 ...

Pharma firm Venus Remedies said it has bagged a contract from Thailand for an anti-cancer drug, Docetaxel, under the govt policy.

Dabur Pharma has entered into an agreement with Government Pharmaceutical Organization of Thailand for the generic of one of its key anti-c...